246 related articles for article (PubMed ID: 16170362)
1. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
[TBL] [Abstract][Full Text] [Related]
2. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
[TBL] [Abstract][Full Text] [Related]
4. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
5. Transforming potential of the insulin receptor substrate 1.
D'Ambrosio C; Keller SR; Morrione A; Lienhard GE; Baserga R; Surmacz E
Cell Growth Differ; 1995 May; 6(5):557-62. PubMed ID: 7647039
[TBL] [Abstract][Full Text] [Related]
6. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
Sun H; Tu X; Baserga R
Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
[TBL] [Abstract][Full Text] [Related]
7. Transformation of late passage insulin-like growth factor-I receptor null mouse embryo fibroblasts by SV40 T antigen.
Spence SL; Shaffer AL; Staudt LM; Amde S; Manney S; Terry C; Weisz K; Nissley P
Cancer Res; 2006 Apr; 66(8):4233-9. PubMed ID: 16618746
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells.
Reiss K; Wang JY; Romano G; Tu X; Peruzzi F; Baserga R
Oncogene; 2001 Jan; 20(4):490-500. PubMed ID: 11313980
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2.
Sun H; Tu X; Prisco M; Wu A; Casiburi I; Baserga R
Mol Endocrinol; 2003 Mar; 17(3):472-86. PubMed ID: 12554758
[TBL] [Abstract][Full Text] [Related]
10. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
12. IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells.
Jackson JG; Yee D
Growth Horm IGF Res; 1999 Oct; 9(5):280-9. PubMed ID: 10543935
[TBL] [Abstract][Full Text] [Related]
13. Role of pescadillo in the transformation and immortalization of mammalian cells.
Maiorana A; Tu X; Cheng G; Baserga R
Oncogene; 2004 Sep; 23(42):7116-24. PubMed ID: 15273728
[TBL] [Abstract][Full Text] [Related]
14. T-antigen of human polyomavirus JC cooperates withIGF-IR signaling system in cerebellar tumors of the childhood-medulloblastomas.
Khalili K; Del Valle L; Wang JY; Darbinian N; Lassak A; Safak M; Reiss K
Anticancer Res; 2003; 23(3A):2035-41. PubMed ID: 12894576
[TBL] [Abstract][Full Text] [Related]
15. The G972R variant of the insulin receptor substrate-1 gene impairs insulin signaling and cell differentiation in 3T3L1 adipocytes; treatment with a PPARgamma agonist restores normal cell signaling and differentiation.
Sentinelli F; Filippi E; Cavallo MG; Romeo S; Fanelli M; Baroni MG
J Endocrinol; 2006 Feb; 188(2):271-85. PubMed ID: 16461553
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.
Chang Q; Li Y; White MF; Fletcher JA; Xiao S
Cancer Res; 2002 Nov; 62(21):6035-8. PubMed ID: 12414625
[TBL] [Abstract][Full Text] [Related]
17. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
[TBL] [Abstract][Full Text] [Related]
18. Regulation of insulin receptor substrate-1 expression levels by caveolin-1.
Chen J; Capozza F; Wu A; Deangelis T; Sun H; Lisanti M; Baserga R
J Cell Physiol; 2008 Oct; 217(1):281-9. PubMed ID: 18506777
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
20. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
